The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has conditionally approved the gene-editing therapy exa-cel (exagamglogene autotemcel), under the…
Articles by Lindsey Shapiro, PhD
Researchers at the University of Tennessee Health Science Center (UTHSC) have received a grant from the U.S. Department of Agriculture…
A scientist whose discoveries paved the way for the development of an investigational gene therapy for sickle cell disease…
Researchers have developed a new way of delivering gene-editing therapies for people with blood disorders such as sickle cell…
Researchers at Rice University in Texas have been awarded $2.6 million to further investigate questions surrounding the safety and efficacy…
The global burden of sickle cell disease (SCD) may be greater than previously thought, with mortality rates up to 11…
A new gene-editing approach called prime editing was able to selectively correct the genetic deficit underlying sickle cell disease…
Despite widespread use of therapies that can influence fertility, few young people with sickle cell disease (SCD) have documented…
Vertex Pharmaceuticals and CRISPR Therapeutics have completed an application to the U.S. Food and Drug Administration (FDA) seeking…
Hemex Health has been awarded $3 million to bring Gazelle, its point-of-care, rapid diagnostic testing device for…